BioMarin Licenses UCSF Technology To Address Cause of Cystic Fibrosis
This article was originally published in The Pink Sheet Daily
Executive Summary
UCSF researcher Alan Verkman will have an ongoing role in lead optimization and development, BioMarin’s CEO tells “The Pink Sheet” DAILY.